CVE-2026-109317Grav API Plugin before 1.0.36 Privilege Escalation via Scalar Access Grants
Updated under an hour ago ()
Does this affect you?
It affects getgrav grav-plugin-api. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.36%, higher than 28% of scored CVEs.
Do this next
Free account, 1 product
Grav grav-plugin-api before 1.0.36 contains a privilege escalation vulnerability that allows delegated user managers to obtain super-admin access by storing positive scalar admin or api parent grants. Attackers with api.users.write can edit account access maps or invitations so the inheriting permission resolver satisfies requireSuper checks, accessing super-only API endpoints.
- CVSS
- 7.2 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-269
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.36% (percentile 28)
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Oct 15, 2026
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
getgrav grav-plugin-api getgrav:grav_plugin_api (from the name) | before 1.0.36; 1.0.36 not affected | CNA record |
References
- https://github.com/getgrav/grav/security/advisories/GHSA-m2rq-76vx-vv4jvendor-advisory, third-party-advisory
- https://www.vulncheck.com/advisories/grav-api-plugin-before-1.0.36-privilege-escalation-via-scalar-access-grantsthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.